Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to dissemintate knowledge & skills of Acute Cardiovascular Care
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission: To promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our goal is to reduce the burden in cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our Mission is "to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death"
To improve quality of life and logevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
Working Groups goals is to stimulate and disseminate scientific knowledge in different fields of cardiology.
ESC Councils goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Mr Dirk De Bacquer,
IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030 D. Whiting et al. Diabetes Res Clin Pract 2011; Advance online publication
Since the year 2000, the International Diabetes Federation (IDF) has consistently been producing worldwide estimates of the prevalence of diabetes according to the latest data available. In their recent 2011 report, IDF collaborators now present updated prevalence figures based on all data sources found from 1980 to 2011 with additional model-based estimates for countries without data.
According to their findings, 366 million people worldwide have diabetes in 2011, including those who were newly diagnosed in surveys and those with type 1 diabetes. From the authors’ projections, diabetes prevalences are anticipated to increase with another 50.7% by 2030 at an averaged annual growth of 1.7 times the annual growth of the total adult world population. Even more worrying, the diabetes pattern varies substantially according to countries’ income status. For countries classified by the World Bank as being high-income countries, most people with diabetes are aged over 60 years, whereas for low- and middle-income countries most people with diabetes are of working age, between 40 and 60 years.
These findings confirm that diabetes prevalences (and incidences) continue to grow globally as expected given the ageing of the population, the unfavourable trends in the prevalence of obesity as observed worldwide but also partially due to a better health care improving longevity of people with diabetes.